For the Quarter Ending听June听2026
听
Carbidopa Prices in听North America
- In the USA, the Carbidopa Price Index rose by 3.56% quarter-over-quarter, reflecting higher freight costs.
- The average Carbidopa price for the quarter was approximately USD 290546.67/MT CFR Los Angeles terms.
- Competitive Asian offers weighed on the Carbidopa Spot Price, tempering the domestic Price Index momentum.
- Container and insurance costs lifted the Carbidopa Production Cost Trend, squeezing supplier netbacks despite shipments.
- Steady neurology offtake supported the Carbidopa Demand Outlook, wholesalers preserved lean inventories ahead of renewals.
- Near-term Carbidopa Price Forecast shows modest oscillation as logistics pressure competes with ample Asian exports.
- Diversion of Asian parcels to Europe tightened availability, nudging the Carbidopa Price Index intermittently higher.
- Regulatory calm and no outages maintained export pipelines, limiting upside for the Carbidopa Spot Price.
Why did the price of Carbidopa change in June 2026 in North America?
- Trans-Pacific freight rose sharply, increasing costs, while abundant Asian exports prevented Los Angeles price increases.
- Indian and Italian plants ran campaigns without outages, supplying ample export volumes to U.S. buyers.
- Medicaid rebate recalculation encouraged wholesalers to run lean inventories, reducing spot buying, softening Price Index.
听
Carbidopa Prices in听APAC
- In China, the Carbidopa Price Index rose by 3.54% quarter-over-quarter, supported by steady exports and runs.
- The average Carbidopa price for the quarter was approximately USD 290396.67/MT measured on FOB Shanghai deliveries.
- Carbidopa Spot Price softened in June as improved feedstock flows increased prompt availability at Shanghai terminals.
- Carbidopa Production Cost Trend remained stable as hydrazine hydrate and aromatic intermediates showed limited volatility recently.
- Carbidopa Demand Outlook stayed constructive overseas with Brazil and India procurement supporting export momentum despite destocking.
- Carbidopa Price Forecast indicates modest oscillations with near-term weakness followed by potential restocking-driven recovery into autumn.
- Carbidopa Price Index reflected exporter concession in June as inventories normalised and buyers exercised increased bargaining.
- Operating rates near eighty-five percent sustained output and exports while shipping war-risk premiums pressured FOB competitiveness.
Why did the price of Carbidopa change in June 2026 in APAC?
- Improved feedstock deliveries post-inspections eased supply tightness, increasing prompt availability and enabling exporters to concede discounts.
- Domestic procurement ceilings reduced hospital API transfer prices, weakening domestic demand and pressuring export FOB offers.
- Elevated war-risk insurance and longer routings increased logistical costs and shipping times, adding upside risk overall.
India
- In India, the Carbidopa Price Index rose by 0.66% quarter-over-quarter, reflecting modest import-cost and restocking pressures.
- Carbidopa Spot Price remained stable in June, supported by routine campaigns and normalised import lead times.
听
Carbidopa Prices in听Europe
- In Germany, the Carbidopa Price Index rose by 3.55% quarter-over-quarter, driven by tighter Asian allocations.
- The average Carbidopa price for the quarter was approximately USD 290521.67/MT, reflecting CFR Hamburg values.
- Carbidopa Spot Price softened in June as abundant offers pressured the Price Index, limiting buying.
- Carbidopa Price Forecast shows volatility while Production Cost Trend reflects higher solvent and freight charges.
- Carbidopa Demand Outlook remains stable as finished-dose offtake steadied, limiting upward pressure on Price Index.
- Major suppliers operated normally; brief rail delays added lead-time risk, sustaining disciplined CFR Hamburg offers.
- Downstream finished-dosage demand remained steady, restraining spot buying and capping near-term upside for Carbidopa buyers.
- Exchange-rate movements were mixed; Price Index sensitivity limited pass-through as importers negotiated contractual spot terms.
Why did the price of Carbidopa change in June 2026 in Europe?
- Increased Asian export allocations in June improved physical availability, exerting downward pressure on German CFR Hamburg prices.
- War-risk premia and elevated freight raised landed-cost risk, yet punctual arrivals and open corridors contained price escalation.
- Domestic offtake remained steady; absence of large tenders reduced urgency, enabling buyers to secure softer spot offers.
For the Quarter Ending March 2026
听
Carbidopa Prices in North America
- In the USA, the Carbidopa Price Index rose by 1.78% quarter-over-quarter, reflecting tighter import availability.
- The average Carbidopa price for the quarter was approximately USD 280561.67/MT, CFR Los Angeles, delivered.
- Carbidopa Spot Price showed upward pressure from rising Shanghai-Los-Angeles freight and precautionary wholesaler restocking activity.
- Carbidopa Price Forecast indicates modest CFR firming as importers increase procurement amid regulatory inspection uncertainty.
- Carbidopa Production Cost Trend reflected higher logistics and potential energy-driven upstream chemical feedstock pressures incrementally.
- Carbidopa Demand Outlook remained stable with steady neurology offtake supporting measured purchasing by manufacturers, wholesalers.
- Carbidopa Price Index movement was constrained by comfortable inventories, long-term contracts, disciplined buyer procurement strategies.
- Export demand, FDA inspections tightened availability, prompting precautionary spot buying that supported firmer CFR offers.
Why did the price of Carbidopa change in March 2026 in North America?
- March price rose due to a sharp Shanghai-Los-Angeles freight increase inflating landed CFR import costs.
- Heightened regulatory scrutiny at Indian sites spurred precautionary wholesaler buying, drawing down available export inventories.
- Sustained neurology demand and procurement, plus long-term contract coverage, limited spot availability causing price pressure.
Carbidopa Prices in APAC
- In China, the Carbidopa Price Index rose by 1.7757% quarter-over-quarter, reflecting modestly firmer export allocations.
- The average Carbidopa price for the quarter was approximately USD 280456.67/MT, based on FOB Shanghai shipments.
- Carbidopa Spot Price remained narrowly ranged as exporters matched steady foreign demand with disciplined dispatches.
- Carbidopa Price Forecast signals modest upside in early second quarter, supported by tightened feedstock availability.
- Carbidopa Production Cost Trend was stable overall, though methanol solvent and aldehyde interruptions increased marginal costs.
- Carbidopa Demand Outlook remains constrained domestically by procurement ceilings while exports supported by Brazil and India restocking.
- Inventory draws reduced port warehouse levels, sustaining the Carbidopa Price Index and tightening available spot volumes.
- Logistics remained fluid with low port congestion, enabling FOB shipments to fulfill overseas contracts without delays.
- Regulatory clearances and successful audits supported export momentum, prompting selective capacity allocation to higher-margin markets.
Why did the price of Carbidopa change in March 2026 in APAC?
- Feedstock supply disruption from Zhejiang inspections tightened aldehyde availability, elevating manufacturing costs and reducing throughput.
- Export restocking by Brazil and India increased short-term overseas demand, drawing down port warehouses and supporting prices.
- Domestic procurement ceilings constrained local offtake, prompting producers to divert volumes to higher-margin export opportunities.
Carbidopa Prices in Europe
- In Germany, the Carbidopa Price Index rose by 1.79% quarter-over-quarter, reflecting modestly firmer import offers.
- The average Carbidopa price for the quarter was approximately USD 280561.67/MT, supporting steady tender volumes.
- Carbidopa Spot Price firmed slightly due to tightened availability after Chinese GMP suspension reduced tonnage.
- Carbidopa Price Forecast anticipates modest gains in April as importers front-load purchases before tender schedules.
- Carbidopa Production Cost Trend edged higher with GMP re-certification and recovery charges increasing exporters' costs.
- Carbidopa Demand Outlook remains stable with steady offtake from Parkinsons formulators and predictable health-insurance tender volumes.
- Carbidopa Price Index movements moderated by adequate Hamburg inventories and uninterrupted shipments from India and Italy.
- Export demand and logistics delays influenced offers while near-term Price Index direction reflected cautious purchasing.
Why did the price of Carbidopa change in March 2026 in Europe?
- Tighter origin availability after GMP suspension reduced spot supply, allowing suppliers to raise offers modestly.
- Higher compliance and solvent-recovery costs pushed exporters' marginal pricing up, feeding into landed CFR values.
- Minor port rail delays increased dwell times and demurrage risk, tightening immediate availability and supporting bids.
For the Quarter Ending December 2025
Carbidopa Price in North America
- In the USA, the Carbidopa Price Index rose by 1.96% quarter-over-quarter, supported by pharmaceutical procurement.
- The average Carbidopa price for the quarter was approximately USD 275658.33/MT, following measured replenishment activity.
- Carbidopa Spot Price remained firm as import allocations prioritized contract manufacturers fulfilling year-end formulations volumes.
- Carbidopa Price Forecast anticipates mild upward momentum driven by steady offtake and constrained domestic volumes.
- Carbidopa Production Cost Trend remained neutral as materials traded sideways while QA expenses slightly increased.
- Carbidopa Demand Outlook remained predictable with hospital and pharmacy replenishment maintaining steady API purchase patterns.
- Carbidopa Price Index movements were moderated by lower freight pass-through and contractual fixed-rate shipping arrangements.
- Inventory at West Coast warehouses stayed lean, prompting measured purchasing that modestly supported CFR offers.
Why did the price of Carbidopa change in December 2025 in North America?
- Steady offtake from Parkinsons therapy manufacturers maintained procurement, supporting modest upward pressure despite logistical improvements.
- Lower container freight reduced transport costs, but fixed annual contracts limited landed-price pass-through to buyers.
- Regulatory compliance and QA expenses at some exporters added landed cost premia, keeping prices elevated.
Carbidopa Price in APAC
- In China, the Carbidopa Price Index rose by 1.96% quarter-over-quarter, supported by firm export demand.
- The average Carbidopa price for the quarter was approximately USD 275563.33/MT, reflecting steady export bookings globally.
- Exporters reported Carbidopa Spot Price remained firm as Latin American and Indian buyers increased procurement.
- Carbidopa Price Forecast indicates modest upside as exporters expect orderly orders and limited spot availability.
- Carbidopa Production Cost Trend stayed subdued due to stable feedstock and unchanged solvent prices globally.
- Carbidopa Demand Outlook remains steady, driven by Parkinsons programmes and disciplined procurement from formulators domestically.
- Moderate-to-low inventories and firm export bookings supported the Carbidopa Price Index, limiting scope for declines.
- Major API plant operations remained routine with no enforcement disruptions, keeping outbound flows reliably steady.
Why did the price of Carbidopa change in December 2025 in APAC?
- Export demand from Brazil and India absorbed volumes, offsetting domestic procurement caps and supporting prices.
- Stable feedstock availability and unchanged solvent costs kept production economics steady, limiting upward cost pressure.
- Port operations and freight avoided logistics premiums, encouraging adherence to contracted allocations rather than re-scheduling.
Carbidopa Price in Europe
- In Germany, the Carbidopa Price Index rose by 1.95% quarter-over-quarter, reflecting measured procurement and steady imports.
- The average Carbidopa price for the quarter was approximately USD 275638.33/MT, reflecting steady contracted procurement patterns.
- Carbidopa Spot Price movements stayed narrow as balanced imports and routine production limited volatility in the Price Index.
- Carbidopa Price Forecast indicates modest upward bias driven by predictable offtake and disciplined importer ordering into Q1.
- Carbidopa Production Cost Trend showed limited pass-through as feedstock and freight movements remained largely stable during December.
- Carbidopa Demand Outlook remains steady with contract manufacturers maintaining regular API pulls for Parkinsons therapies through year-end.
- Carbidopa Price Index rose slightly as moderate inventories and uninterrupted exports kept supply-demand balance tight without sharp spikes.
- Major producers operated planned campaigns; German domestic output remained subdued due to high electricity tariffs and limited local availability.
Why did the price of Carbidopa change in December 2025 in Europe?
- Balanced import volumes and scheduled API campaigns prevented acute shortages, limiting upward price pressure effectively.
- Stable freight and port operations removed logistical premiums, restraining cost pass-through into the Carbidopa Price Index.
- Predictable pharmaceutical demand and conservative inventory rebuilds kept buying measured, supporting only marginal index increases.
For the Quarter Ending September 2025
North America
鈥� In USA, the Carbidopa Price Index rose by 0.34% quarter-over-quarter, reflecting modest imbalances from stockpile adjustments.
鈥� The average Carbidopa price for the quarter was approximately USD 270350/MT, representing distributor-level weighted average.
鈥� Carbidopa Spot Price eased in August as logistics costs normalized and inventory overhang reduced urgent purchasing pressures.
鈥� Carbidopa Price Forecast indicates gradual recovery supported by restocking, yet constrained by trade policy uncertainty and inflation.
鈥� Carbidopa Production Cost Trend shows limited upward pressure from freight and handling, while feedstock costs remain benign.
鈥� Carbidopa Demand Outlook remains subdued into September as buyers prioritize inventory normalization over speculative replenishment amid policy risk.
鈥� Carbidopa Price Index volatility reflected short-term congestion relief, restocking waves, and cautious distributor margin restoration measures.
鈥� Inventory buffers expanded after June stockpiling, reducing immediate import urgency and tempering spot bids across US distribution channels.
Why did the price of Carbidopa change in September 2025 in North America?
鈥� Reduced import volumes after pre-season stockpiling eased supply tightness, prompting sellers to lower bid levels.
鈥� Normalized freight rates and eased port congestion decreased landed costs, enabling suppliers to offer more competitive pricing.
鈥� Cautious buyer behavior and inventory normalization suppressed demand, increasing pressure on spot trades and transactional volumes.
APAC
鈥� In China, the Carbidopa Price Index rose by 0.35% quarter-over-quarter during 2025, reflecting demand weakness.
鈥� The average Carbidopa price for the quarter was approximately USD 270253.33/MT from exporters/formulators.
鈥� Carbidopa Spot Price softened as inventories accumulated, pressuring exporters to offer volumes and lead times.
鈥� Carbidopa Price Forecast indicates modest gains ahead, driven by selective restocking and gradual inventory normalization.
鈥� Carbidopa Production Cost Trend showed reduced logistics and input pressures but weather-related cost spikes persisted.
鈥� Carbidopa Demand Outlook remains cautious with Western buyers deferring purchases, limiting sustained upward price momentum.
鈥� Carbidopa Price Index volatility was influenced by declining freight costs and typhoon-related port delays persisting.
鈥� Producers adjusted output schedules; smaller exporters may consolidate as margins tightened, moderating near-term market recovery.
Why did the price of Carbidopa change in Sep 2025 in APAC?
鈥� Oversupply and accumulated inventories pressured sellers, prompting discounting to stimulate offtake during September shipment period.
鈥� Lower spot container freight rates reduced exporter cost pressure, giving buyers leverage in price negotiations.
鈥� Muted international demand and purchasing strategies led buyers to defer orders, limiting price recovery momentum.
Europe
鈥� In Germany, the Carbidopa Price Index rose by 0.3563% quarter-over-quarter, reflecting elevated inventories and soft demand.
鈥� The average Carbidopa price for the quarter was approximately USD 270356.67/MT, based on CFR Hamburg transactions.
鈥� Carbidopa Spot Price softened as distributors liquidated older stock, keeping the Carbidopa Price Index subdued.
鈥� Carbidopa Price Forecast anticipates recovery as postponed PSS activations and restocking drive higher import costs.
鈥� Carbidopa Production Cost Trend showed upward pressure from freight surcharges and logistics inefficiencies, elevating landed costs.
鈥� Carbidopa Demand Outlook remains cautious, with healthcare buyers prioritizing inventory optimization over aggressive purchasing this quarter.
鈥� High inventory buffers and steady exports constrained price rallies, keeping the Carbidopa Price Index largely rangebound.
鈥� Selective restocking followed port congestion easing, with producers maintaining regular operations and availability to markets.
Why did the price of Carbidopa change in September 2025 in Europe?
鈥� Elevated inventories and subdued purchasing reduced immediate spot demand, applying downward pressure on local pricing.
鈥� Postponed PSS activations plus port congestion increased uncertainty and freight costs, prompting cautious buying decisions.
鈥� Import timing shifts and delayed shipments tightened short-term availability intermittently, supporting selective price recoveries periodically.
